Breast cancer can return – this is known as metastatic breast cancer or advanced cancer – and when it does, the treating physician and the patient will look for alternatives that allow her to prolong and maintain a good quality of life.
This is the reality of 30% of women who have had breast cancer and the situation of a significant number of women.
To share clinical evidence and provide input for decision-making, Dr. Saúl Campos-Gómez, an oncologist at the Social Security Institute of Mexico, and Dr. Isabel Blancas, an oncologist at the San Cecilio Clinical Hospital in Granada, Spain, recently met with doctors to review the clinical information on innovative drugs, which show that the combination of iCDK 4/6 therapies and endocrine therapy have better results than those who receive chemotherapy.
This would allow patients to redefine their overall survival expectations and have more time to carry out activities and be part of events that are important to them.
Overall survival is defined as the percentage of patients who are still alive after a certain period following diagnosis or treatment for a disease such as cancer.
It is one of the most relevant characteristics for doctors and patients when choosing a particular therapy.
In 2017, a survey was conducted among oncologists and patients with breast cancer to understand the therapeutic goals in the treatment of this pathology and both parties agreed that the main goal is overall survival.
Therefore, the goal of treatment for advanced breast cancer is to help the patient live longer and do so with a good quality of life, even in cases that are considered more difficult.
In this regard, Novartis has managed to advance with an oral therapy that overcomes chemotherapy and its adverse effects, facilitating adherence to treatment with longer overall survival time and clinical safety.
This information is of interest to the medical community due to its relevance in guiding decision-making and making cost-effectiveness considerations.
Active screening and diagnosis of breast cancer in the early stages improves the chances of successful cure and survival.
Breast cancer is the second most common cause of cancer in the world and the most common cancer among women. It is ideal for women over 40 to have regular check-ups with their doctor, so that they can be prescribed preventive imaging studies (mammography and/or ultrasound) promptly, as appropriate, and thus achieve early diagnosis of the disease, all of which translates into better treatment results.
+ There are no comments
Add yours